
Encompass Health (EHC) | Stock Overview & Key Data
Encompass Health Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: $127.86 on September 23, 2025
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Financial Highlights
Profitability
Returns and Earnings
Growth
Dividend Information
Peer Performance Comparison
Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
---|---|---|---|---|---|---|---|---|---|
Encompass Health EHC | 12.63B Large-cap | -2.74% | -0.32% | 3.52% | 20.97% | 34.16% | 30.40% | 154.40% | 131.07% |
HCA Healthcare HCA | 100.93B Large-cap | 2.50% | 5.38% | 14.06% | 23.03% | 44.26% | 9.00% | 114.28% | 220.65% |
Tenet Healthcare THC | 17.99B Large-cap | 0.50% | 8.61% | 18.37% | 52.79% | 62.11% | 29.65% | 277.46% | 613.03% |
Universal Health UHS | 13.19B Large-cap | 3.18% | 14.14% | 12.31% | 9.81% | 15.34% | -3.91% | 126.67% | 85.48% |
Ensign Group ENSG | 10.12B Large-cap | 1.68% | 2.18% | 16.79% | 30.99% | 32.01% | 21.59% | 112.61% | 194.79% |
DaVita DVA | 9.39B Mid-cap | 0.28% | -3.54% | -8.00% | -14.68% | -12.45% | -18.38% | 50.46% | 49.28% |
Ownership & Short Interest
Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is EHC's 52-week high and low?
- In the last 52 weeks, Encompass Health reached a high of $127.86 (on September 23, 2025) and a low of $87.85 (on January 3, 2025).
- What is the market cap and P/E ratio for EHC?
- Curious about Encompass Health's size and valuation? Its market capitalization stands at 12.63B. When it comes to valuation, the P/E ratio (trailing twelve months) is 24.02, and the forward P/E (looking ahead) is 25.78.
- Does EHC pay dividends? If so, what's the yield?
- Yes, Encompass Health is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.55%, and the company has paid an average of $3.68 per share annually over the past 3 years.
- Who are Encompass Health's main competitors or similar companies to consider before investing?
When looking at Encompass Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return HCA Healthcare
HCA100.93B Healthcare Medical Care Facilities 9.00% 114.28% Tenet Healthcare
THC17.99B Healthcare Medical Care Facilities 29.65% 277.46% Universal Health
UHS13.19B Healthcare Medical Care Facilities -3.91% 126.67% Ensign Group
ENSG10.12B Healthcare Medical Care Facilities 21.59% 112.61% DaVita
DVA9.39B Healthcare Medical Care Facilities -18.38% 50.46% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Encompass Health Corporation? (e.g., ROE, Debt/Equity)
- To get a sense of Encompass Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 24.72%, the Debt to Equity ratio from the most recent quarter is 86.97, and its Gross Profit Margin stands at 43.01%.
- What is the recent revenue and earnings growth for EHC?
- Looking at Encompass Health's growth, its revenue over the trailing twelve months (TTM) was $6B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.00%, and quarterly earnings saw a YoY growth of 24.50%.
- How much of EHC stock is held by insiders and institutions?
- Wondering who owns Encompass Health stock? Company insiders (like executives and directors) hold about 1.41% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 96.55%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.